ArticleCureus2026
Coronary Embolism: A Rare Complication After Takotsubo Cardiomyopathy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Takotsubo cardiomyopathy (TTC) is a transient stress-induced cardiomyopathy characterized by reversible left ventricular (LV) systolic dysfunction that mimics acute coronary syndrome. Although most patients recover ventricular function, severe LV dysfunction may result in LV thrombus formation and systemic embolization. Coronary embolism is an exceptionally rare complication of TTC and may present as ST-elevation myocardial infarction (STEMI). We report a rare case of coronary embolism complicating TTC in a patient with multiple thromboembolic risk factors. A 74-year-old woman with chronic obstructive pulmonary disease, tobacco use, dyslipidemia, generalized anxiety disorder, and a history of unprovoked deep vein thrombosis and pulmonary embolism on apixaban presented with chest pain and dyspnea two days after cataract surgery. Apixaban had been withheld for three days preoperatively. Electrocardiography demonstrated inferior and anterolateral ST-segment elevation, and cardiac biomarkers were markedly elevated. Emergent coronary angiography revealed embolic occlusion of the distal obtuse marginal branch without obstructive coronary artery disease, requiring thrombectomy and balloon angioplasty. Left ventriculography demonstrated classic apical ballooning with an LV mural thrombus, while transthoracic echocardiography showed an ejection fraction of 15-20% with severe global wall-motion abnormalities. The patient was diagnosed with TTC complicated by LV thrombus and coronary embolism and was treated with dual antiplatelet therapy, anticoagulation, guideline-directed medical therapy, and a wearable cardioverter-defibrillator. This case illustrates the diagnostic challenge posed by the overlapping presentation of TTC and coronary embolism. Severe LV dysfunction, apical akinesis, perioperative interruption of anticoagulation, prior venous thromboembolism, tobacco use, and a newly identified pulmonary nodule likely contributed to a multifactorial hypercoagulable state. Unlike the typical mechanism in which embolization occurs during recovery of ventricular function, coronary embolism developed during the acute phase of TTC. This case also highlights the importance of evidence-based perioperative management of direct oral anticoagulants to minimize thromboembolic risk in high-risk patients. Coronary embolism is a rare but potentially fatal complication of TTC. Early recognition, prompt coronary intervention, anticoagulation, and multidisciplinary management are essential to optimize outcomes. Careful perioperative anticoagulation planning and further research are needed to better identify patients at highest risk for thromboembolic complications and to refine preventive strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.